The influence of isoflavone for denervation-induced muscle atrophy

Shinpei Tabata1, Miki Aizawa1, Masakazu Kinoshita1

  • 1Research Center for Physical Fitness, Sports and Health, Toyohashi University of Technology, 1-1 Hibarigaoka, Tenpaku-cho, Toyohashi, 441-8580, Japan.

Abstract

Insights

Dietary isoflavone aglycone (AglyMax) at 0.6% attenuated denervation-induced muscle atrophy in mice by reducing apoptosis. This suggests a potential therapeutic role for isoflavones in preventing muscle wasting diseases.

Area of Science:

  • Muscle physiology
  • Cellular signaling
  • Nutritional science

Background:

  • Skeletal muscle atrophy results from decreased activity.
  • Previous research indicated high-dose isoflavones inhibit short-term denervation-induced atrophy.
  • Isoflavones are plant-derived compounds with potential health benefits.

Purpose of the Study:

  • To investigate if a 0.6% dietary dose of isoflavone aglycone (AglyMax) prevents muscle atrophy after denervation in mice.
  • To determine if AglyMax modulates atrogin-1 or apoptosis-dependent signaling pathways.

Main Methods:

  • Mice were fed a normal or 0.6% AglyMax diet for one week.
  • Sciatic nerve denervation was performed.
  • Gastrocnemius muscle was analyzed for wet weight, fiber area, atrogin-1, cleaved caspase-3, and apoptotic nuclei at 14 days post-denervation.

Main Results:

  • The 0.6% AglyMax diet significantly reduced denervation-induced fiber atrophy but not muscle wet weight.
  • Dietary isoflavone suppressed apoptosis, despite no significant change in cleaved caspase-3 protein.
  • AglyMax did not significantly alter atrogin-1 protein expression in denervated muscle.

Conclusions:

  • A 0.6% AglyMax diet significantly mitigates muscle atrophy following denervation in mice.
  • This protective effect is likely mediated by a reduction in apoptosis-dependent signaling.
  • Isoflavone aglycone shows potential for managing denervation-induced muscle atrophy.